Literature DB >> 23507597

[Evaluation of the efforts of pharmaceutical care services before medical examination at an outpatient cancer chemotherapy clinic].

Chiaki Yoshimi1, Maya Yamada, Hironori Fujii, Minako Nishigaki, Hirotoshi Iihara, Kiyoyuki Kitaichi, Mayu Takahashi, Sayoko Kurahashi, Takao Takahashi, Kazuhiro Yoshida, Yoshinori Itoh.   

Abstract

In the outpatient cancer chemotherapy clinic of Gifu University Hospital, pharmacists contributed to the provision of safe and efficacious cancer chemotherapy as full-time staff, together with doctors, nurses and other medical staff. Since April 2010, three pharmacists have been in charge of the provision of pharmaceutical care services(PCS)to all patients. Furthermore, pharmaceutical intervention before medical examination(pre-PCS)was initiated in May 2011. As a consequence, the time spent for patient education and monitoring significantly(p<0. 001)increased from 39. 7±3. 2min/patient in 2010 to 48. 0±2. 6min/patient in 2011. The number of proposals on prescriptions also significantly increased, 2. 5 times, compared to 2010. The percentage of the acceptance of proposals was 94% in fiscal year 2011. Importantly, pre-PCS improved the control of chemotherapy-induced nausea and vomiting, peripheral neuropathy and skin rash. These results suggest that pre-PCS by pharmacists would be beneficial to progress the quality of outpatient cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507597

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Patients' perception of pharmaceutical services available in a community pharmacy among patients living in a rural area of the United Kingdom.

Authors:  Piotr Merks; Damian ŚWieczkowski; Miłosz J Jaguszewski
Journal:  Pharm Pract (Granada)       Date:  2016-09-15

2.  Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.

Authors:  Chiemi Hirose; Hironori Fujii; Hirotoshi Iihara; Masashi Ishihara; Minako Nawa-Nishigaki; Hiroko Kato-Hayashi; Koichi Ohata; Kumiko Sekiya; Mika Kitahora; Nobuhisa Matsuhashi; Takao Takahashi; Kumiko Okuda; Masayo Naruse; Takuma Ishihara; Tadashi Sugiyama; Kazuhiro Yoshida; Akio Suzuki
Journal:  Support Care Cancer       Date:  2020-04-12       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.